Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

ClinicalTrials.gov ID: NCT02633956

Public ClinicalTrials.gov record NCT02633956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2, double-blind, randomized, placebo-controlled, multicenter study, with an open-label long-term safety extension (LTSE), will evaluate the effect of Obeticholic Acid, and the subsequent addition of statin therapy, on lipoprotein metabolism in subjects with nonalcoholic steatohepatitis (NASH) with fibrosis stage 1 to 4, but no evidence of hepatic decompensation.

Study identification

NCT ID
NCT02633956
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Intercept Pharmaceuticals
Industry
Enrollment
84 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2015 (Actual)
Primary completion
Mar 21, 2017 (Actual)
Completion
Mar 12, 2018 (Actual)
Last update posted
Jun 4, 2018

2015 – 2018

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
Scripps Clinic La Jolla California 92037 —
Inland Empire Liver Foundation Rialto California 92377 —
Nature Coast Clinical Research Inverness Florida 34452 —
University of Miamai, Schiff Center for Liver Diseases Miami Florida 33136 —
South Florida Center of Gastroenterology Wellington Florida 33414 —
Florida Medical Clinic, P.A. Zephyrhills Florida 33542 —
The Queen's Medical Center - Liver Center Honolulu Hawaii 96813 —
Mercy Medical Center, Institute for Digestive Health & Liver Disease Baltimore Maryland 21202 —
Kansas City Research Institute Kansas City Missouri 64131 —
St. Louis University St Louis Missouri 63104 —
Duke University Medical Center Durham North Carolina 27710 —
Cumberland Research Associates, LLC Fayetteville North Carolina 28304 —
Consultants for Clinical Research Cincinnati Ohio 45249 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
University Gastroenterology Liver Center Providence Rhode Island 02905 —
Medical University of South Carolina Charleston South Carolina 29425 —
ClinSearch Chattanooga Tennessee 37421 —
Texas Clinical Research Institute, LLC Arlington Texas 76012 —
Liver Associates of Texas, P.A. Houston Texas 77030 —
American Research Corporation at the Texas Liver Institute San Antonio Texas 78215 —
McGuire DVAMC Richmond Virginia 23249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02633956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2018 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02633956 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →